ATYPICAL FIBROXANTHOMA

Clinical trials for ATYPICAL FIBROXANTHOMA explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL FIBROXANTHOMA trials appear

Sign up with your email to follow new studies for ATYPICAL FIBROXANTHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for tough sarcomas: adding a targeted drug to standard treatment

Disease control Ongoing

This study is for patients with newly diagnosed, high-risk soft tissue sarcomas that can be removed by surgery. It tests whether adding a drug called pazopanib to standard pre-surgery treatments (radiation with or without chemotherapy) helps shrink tumors more effectively and imp…

Matched conditions: ATYPICAL FIBROXANTHOMA

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

ATYPICAL FIBROXANTHOMA

Get alerted when new ATYPICAL FIBROXANTHOMA trials appear

New hope for tough sarcomas: adding a targeted drug to standard treatment